U.S. markets closed

Identiv, Inc. (INVE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.67+0.10 (+0.64%)
At close: 4:00PM EDT
Sign in to post a message.
  • j
    jonie
    Yawn. Low volume and no news. At least (and surprisingly) we’re still holding $15. No pre-announcement like last quarter, so hoping for the best. I know this will pop when the syringe is FDA approved and/or the marijuana business kicks in but this earnings call will need to stand on its own. Glta
  • j
    jonie
    Does anybody know how almost 2.5mm shares were traded, mostly at or after close, and we are down so much? I assume the huge volume is related to the Russell rebalancing effective Monday but why the price drop and where did all of those shares come from?
  • B
    Bobby
    Wow, they actually named customers in their PR today... that's got to be a first? Very encouraging either way.
  • D
    Dr Sweet
    The highest share price in many years... I first bought INVE in 2011 and thought is could be a $50/shr back then. The reality sank in by 2013, but I'm glad I let it sit instead of taking my losses.
    Bullish
  • j
    jonie
    We need need meaningful news or some other catalyst (e.g., analyst upgrade, positive story etc.)
  • r
    rob
    I was just on the Identiv company website and it appears as though that syringe they mentioned on the earnings call is actually for sale in the market and it also appears to be an Identiv branded product. Does anyone have a better understanding of this recent announcement?? Please post if you do.
  • j
    jonie
    Excellent Seeking Alpha article came out Saturday with spot on analysis of Inve’s prospects, focusing on the syringe and cannabis opportunities. The author says this should be at $26 now, using a 5 x 2022 sales multiple, and that top line will exceed $250mm by 2024 if Inve delivers on the syringe and cannabis pipelines and other innovative products. I agree.
  • D
    David
    Well the reaction to earnings is great. Hoping the analysts upgrade or at least re-iterate their buy ratings and price targets. Anyone think this can get to $18 to $20??
  • z
    zappasrevenge
    Just listened to the replay of the call. Whatever the short term impact on the pps may be, we should all hold on to our shares and wait for the things to come. Their pipeline is good, their number of major leads seems to be growing steadily and they are careful with spending. Also, the offering has been used not only to improve the balance sheet, but also for development and capacity. They have learned their lesson from the past and are now pretty conservative in what they predict. Better than the other way round. For the next call, the only question will be how much they raise the forecast not if. Future is bright for INVE.
    Bullish
  • D
    Dr Sweet
    Hold!
  • j
    jonie
    Well, no official Apple or guidance surprise but the new rfid Fortune 500 customer is interesting. I think Bobby’s call for 12s will be right. I expected more from the company. Hopefully, Steve can pump it up.
  • j
    jonie
    Predictions?
  • J
    JCZZY
    I wrote on this board back in December that INVE's stock price was a joke and how the stock will easily be $15-20 by 2H this year due to RFID growing faster than expectations. The stock is up since then but I look at the stock price right now and it's still a joke.

    On the call, Steve said that he can't name companies, but that he's in "accessories for mobile devices." The only company that's making NFC accessories for phones is Apple w/ Magsafe!!! He then said that they are launching at least two new designs for the large customer in 2021. Airtags!!

    And we already knew they were the ones behind CVS's Spoken RX and now they added another pharmacy customer "of similar scale." Anyone else notice the new customer logo w/ a cannabis customer, Edison cannabis? Another huge market that the market is ignoring. It may be another year or two for cannabis to take off, but I bet it'll be the largest market in 3-5 years in terms of value.

    In Nov, Steve guided RFID growth to be 20-25% for 2021. Yet, a guy who's super conservative, somehow built enough capacity for 50% growth. It's not hard to put two and two together here, folks.

    Oh, and the premises biz looks fine. Federal growing strong and they are going to get great publicity for securing the Capitol Building. Once the economy opens up, hotels and retail (where they were more exposed to on the commercial side) will see a strong rebound.

    Finally, Steve said that he thinks margins are already at the inflection point and gross margins will increase to the 40's in a quarter or two but opex will not go up in 2021. So now, we have a case of where sellside is too conservative on revenues AND margins.

    Again, the stock price is an absolute joke.
  • M
    MC1999
    Humphreys deserves credit for getting us to GAAP-positive EBITDA. I believe they've focused on their core the past couple of years and resulted in a nice, solid company. This is now a responsibly run company with a good management team. My hope is new investors can start disconnecting the present & future from previous regimes. We need a couple more profitable quarters and a profitable 2020. That said, I don't see hockey stick growth on the revenue side (even with the Thursby/3VR acquisitions, we now seem like a very conservative organization). Maybe we take our trifecta of Physical Access, Video Surveillance, and Authentication and look for a buyer in 2020??
    Bullish
  • T
    Tweet
    *Disclaimer: I am not a professional and this is not financial advice.*

    The Chart of the Day belongs to the security technology company *Identiv ($INVE)*. I found the stock by using Barchart's powerful screening tools to find the stocks with the highest Weighted Alpha and technical buy signals. After I sorted for the most frequent number of new highs in the last month, I used the Flipchart feature to review the charts for consistent prices appreciation. Since the Trend Spotter signaled a buy on 1/22 the stock gained 40.36%.

    Identiv, Inc. operates as a security technology company that secures data, physical places, and things worldwide. It operates through two segment, Premises and Identity. The Premises segment offers modular Hirsch MX controllers that allow customers to start with a small system and expand over time; Hirsch Velocity software platform for centralized management of access and security operations across an organization; federal identity, credential and access management architecture, an access control system; TouchSecure door readers that provide various features to support security standards; and global services to support system design, deployment, and managed services across customers premises security lifecycle. The Identity segment provides smart card readers, which include various contact, contactless, portable, and mobile smart card readers, as well as tokens and terminals to enable logical access, and security and identification applications, such as national ID, payment, e-health, and e-government. The company also offers near field communication and radio frequency identification products, including inlays and inlay-based; labels and tags, as well as other radio frequency and integrated circuits components for use in various applications, such as virtual reality, games, loyalty cards, mobile payment systems, transit and event ticketing, and brand authenticity foe pharmaceuticals, consumer goods, hospital resource management, cold-chain management, and others; and access cards. It markets and sells its products through original equipment manufacturers, dealers, systems integrators, value added resellers, resellers, and Internet, as well as directly to end users. Identiv, Inc. has a strategic partnership with CertiPath. The company was formerly known as Identive Group, Inc. and changed its name to Identiv, Inc. in May 2014. Identiv, Inc. was founded in 1990 and is headquartered in Fremont, California.

    [view the chart ](https://static.seekingalpha.com/uploads/2021/2/11/366229-1613071605521091_origin.png)

    Barchart technical indicators:

    - 100% technical buy signals
    - 188.50+ Weighted Alpha
    - 123.94% gain in the last year
    - Trend Spotter buy signal
    - Above its 20, 50 and 100 day moving averages
    - 15 new highs and up 52.82% in the last month
    - Relative Strength Index 82.88%
    - Technical support level at 10.67
    - Recently traded at 11.76 with a 50 day moving average of 8.11

    Fundamental factors:

    - Market Cap $203 million
    - Revenue expected to grow 3.70% this year and another 15.10% next year
    - Earnings estimated to increase 93.30% next year
    - Wall Street analysts issued 3 buy recommendations on the stock
    - The individual investors following the stock om Motley Fool vote 33 to 4 that the stock will beat the market
    - 3,020 investors are monitoring the stock on Seeking Alpha

    TL:DR: $INVE to the moon!
  • z
    zappasrevenge
    @Bobby in particular due to his insights, but @all in general.

    I am a long time shareholder from Germany. I think that the current management is doing a pretty good job, (mostly) deliver on what they promise, the company is stable now and on a good path. Hopefully gradually leaving (as Jason Hart would have put it) the penalty box. This might take some more time. I am confident. Here is my point and where I would appreciate your thoughts.

    The company seems to be undervalued. I think this is almost exclusively due to a missing buying side. Only three analysts following. Nobody knows INVE. The recent climb mainly based on Bleichroeder buying shares to get to a 20% now. Are there any rumors or indications in the market that they might get Identive ready for sale? I mean otherwise why the 20% share if no one is interested and no real appropriate and sustainable rise in share price? I know, we come from $ 2+ a year ago but that was a joke. I guess the plan is to sell it. Which might be the best idea anyway.

    Thanks.
  • I
    Itisme444
    Great to see Identiv is focused on getting the right Covid-19 management solutions, for getting people back to Normal Life! 1) First, it delivers a temperature sensitive wrist band based Covid-19 Mgt solution to a large US Theme Park (0.5 Billion visitors per year, Disney?), and got Major Backlog of Orders to ship in 2nd half of 2020, 2) Now, Helping Government, Defense, & Enterprises to monitor visitors with today's PR, 3) Personally, I hope to see Identiv extend the Theme park based Wrist Band solution to its Government, Defense, Enterprise Employees, as well as, for the Students, to get them back to offices and Schools/ Colleges/ Universities with better peace of mind!
  • J
    JCZZY
    INVE's recent stock performance makes me laugh. Lake Street came out with a report last week that basically linked INVE with Apple's MagSafe product which means that Apple is the "big customer." Let me repeat, Apple is the big customer! INVE has said that they are already designing new products for the big customer coming out next year (AirTags, anyone?). An even bigger plus: INVE has said that the big customer continually changes designs, making it harder for others to come in and take INVE's share. Apple sells almost 200mm phones a year -- draw your own conclusions on the attach rate of the various accessories that will have NFC in them. Remember, this isn't just for Apple-branded accessories. Other accessory makers will probably look to INVE to help launch their NFC-enabled products as well.

    Lake Street also connected INVE with CVS's Spoken Rx product. It's going from 1500 locations this year to all of their stores next year (9,900 locations.) https://www.pymnts.com/news/retail/2020/cvs-pharmacy-creates-spoken-rx-to-read-prescription-labels/

    Then, you have other potential opportunities in healthcare logistics like vaccine temperature tracking or even cannabis packaging and the stock can easily double or triple from here.

    Easily a $15-$20 stock by 2H of next year when INVE raises estimates.
    CVS Pharmacy has created a new function of its app called Spoken RX to provide patients with “talking” prescription labels.
    CVS Pharmacy has created a new function of its app called Spoken RX to provide patients with “talking” prescription labels.
    www.pymnts.com
    Bullish
  • D
    David
    Total dilemma of whether to sell or not. I'm finally up huge after 5+ years of bag holding. All gains are now long term for tax basis. The company is in much better position, but I feel like it's wrong to not sell some when it's up this far from the $3 buck level. Now that my gains are long term, if I sell and buy something else, I'd have to hold for a year to get the favorable long term tax treatment of 15% in a new investment, so I want to keep holding. Is this being greedy?? I just think back to all the years it was 2.50 to 5 and I'd have given my left arm to be able to sell this high.
    Neutral
  • J
    JCZZY
    Nice preannouncement from INVE. Buried in there is this blurb, "...the company believes that full-year guidance ranges may be somewhat conservative considering the current business momentum."

    They will very likely formally raise guidance on the March 4th call.
    https://www.globenewswire.com/news-release/2021/02/09/2172075/0/en/Identiv-s-Operational-Momentum-Sets-Positive-Outlook-for-2021.html
    Preliminary 4th Quarter 2020 Revenue of $24.6 to $24.8 Million, 30% Growth Year-Over-Year and Positive Cash Flow from Operations
    Preliminary 4th Quarter 2020 Revenue of $24.6 to $24.8 Million, 30% Growth Year-Over-Year and Positive Cash Flow from Operations
    www.globenewswire.com
    Bullish